243 related articles for article (PubMed ID: 29311919)
1. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.
Bellusci L; Laurino A; Sabatini M; Sestito S; Lenzi P; Raimondi L; Rapposelli S; Biagioni F; Fornai F; Salvetti A; Rossi L; Zucchi R; Chiellini G
Front Pharmacol; 2017; 8():905. PubMed ID: 29311919
[TBL] [Abstract][Full Text] [Related]
2. Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents Through the Modulation of SIRT6.
Bellusci L; Runfola M; Carnicelli V; Sestito S; Fulceri F; Santucci F; Lenzi P; Fornai F; Rapposelli S; Origlia N; Zucchi R; Chiellini G
Molecules; 2020 Feb; 25(5):. PubMed ID: 32110992
[TBL] [Abstract][Full Text] [Related]
3. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
4. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
[TBL] [Abstract][Full Text] [Related]
5. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
[No Abstract] [Full Text] [Related]
6. Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.
Tremmel E; Hofmann S; Kuhn C; Heidegger H; Heublein S; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
Breast Cancer (Dove Med Press); 2019; 11():87-97. PubMed ID: 30858725
[TBL] [Abstract][Full Text] [Related]
7. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
8. Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.
Zhang X; Mantas I; Alvarsson A; Yoshitake T; Shariatgorji M; Pereira M; Nilsson A; Kehr J; Andrén PE; Millan MJ; Chergui K; Svenningsson P
Front Pharmacol; 2018; 9():166. PubMed ID: 29545750
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.
Cöster M; Biebermann H; Schöneberg T; Stäubert C
Eur Thyroid J; 2015 Sep; 4(Suppl 1):9-20. PubMed ID: 26601069
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
[TBL] [Abstract][Full Text] [Related]
11. T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line.
Polini B; Ricardi C; Bertolini A; Carnicelli V; Rutigliano G; Saponaro F; Zucchi R; Chiellini G
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511328
[TBL] [Abstract][Full Text] [Related]
12. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
[TBL] [Abstract][Full Text] [Related]
13. Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway.
Rogowski M; Bellusci L; Sabatini M; Rapposelli S; Rahman SM; Chiellini G; Assadi-Porter FM
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434215
[TBL] [Abstract][Full Text] [Related]
14. Update on 3-iodothyronamine and its neurological and metabolic actions.
Zucchi R; Accorroni A; Chiellini G
Front Physiol; 2014; 5():402. PubMed ID: 25360120
[TBL] [Abstract][Full Text] [Related]
15. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
Rutigliano G; Bandini L; Sestito S; Chiellini G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183490
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold.
Manni ME; De Siena G; Saba A; Marchini M; Landucci E; Gerace E; Zazzeri M; Musilli C; Pellegrini-Giampietro D; Matucci R; Zucchi R; Raimondi L
Br J Pharmacol; 2013 Jan; 168(2):354-62. PubMed ID: 22889145
[TBL] [Abstract][Full Text] [Related]
17. The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling.
Dinter J; Khajavi N; Mühlhaus J; Wienchol CL; Cöster M; Hermsdorf T; Stäubert C; Köhrle J; Schöneberg T; Kleinau G; Mergler S; Biebermann H
Eur Thyroid J; 2015 Sep; 4(Suppl 1):21-9. PubMed ID: 26601070
[TBL] [Abstract][Full Text] [Related]
18. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
Chiellini G; Bellusci L; Sabatini M; Zucchi R
Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
[TBL] [Abstract][Full Text] [Related]
19. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells.
Rogowski M; Gollahon L; Chellini G; Assadi-Porter FM
FEBS Open Bio; 2017 Apr; 7(4):587-601. PubMed ID: 28396842
[TBL] [Abstract][Full Text] [Related]
20. T
Tozzi F; Rutigliano G; Borsò M; Falcicchia C; Zucchi R; Origlia N
Neurobiol Dis; 2021 Apr; 151():105271. PubMed ID: 33482355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
